Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy. Gattringer T, Enzinger C, Khalil M, Schwingenschuh P, Pichler A, Moser A, Graninger W, Ernst C, Haybaeck J, Fazekas F Neurol Neuroimmunol Neuroinflamm. 2014 Jun; 1(1):e1. Epub 2014 Apr 24. PMID: 25340053. Abstract CommentRecommendBookmarkWatch